Last reviewed 2026-04-23 · How we verify

AQ4N

Novacea · Phase 1 active Small molecule

At a glance

Generic name	AQ4N
Sponsor	Novacea
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

AQ4N CI brief — competitive landscape report
AQ4N updates RSS · CI watch RSS
Novacea portfolio CI